Neonatal herpes simplex virus infection: epidemiology and treatment.

[1]  Lawrence Corey,et al.  138 – Herpes Simplex Virus , 2015 .

[2]  D. Isaacs,et al.  Population-based surveillance of neonatal herpes simplex virus infection in Australia, 1997-2011. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  D. Kimberlin.  The scarlet H. , 2014, The Journal of infectious diseases.

[4]  R. Whitley,et al.  Herpes simplex virus. , 2014, Handbook of clinical neurology.

[5]  G. Mcquillan,et al.  Seroprevalence of herpes simplex virus types 1 and 2--United States, 1999-2010. , 2014, The Journal of infectious diseases.

[6]  Gary Dubin,et al.  Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  D. Kimberlin,et al.  Guidance on Management of Asymptomatic Neonates Born to Women With Active Genital Herpes Lesions , 2013, Pediatrics.

[8]  D. Kimberlin,et al.  Maternal and Neonatal Herpes Simplex Virus Infections , 2013, American Journal of Perinatology.

[9]  C. Leach,et al.  Neonatal herpes disease following maternal antenatal antiviral suppressive therapy: a multicenter case series. , 2012, The Journal of pediatrics.

[10]  P. Marques‐Vidal,et al.  Seroepidemiology of herpes simplex virus type 1 and 2 in pregnant women in Switzerland: an obstetric clinic based study. , 2012, European journal of obstetrics, gynecology, and reproductive biology.

[11]  D. Powell,et al.  Oral acyclovir suppression and neurodevelopment after neonatal herpes. , 2011, The New England journal of medicine.

[12]  D. Shukla,et al.  Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry , 2009, The FEBS journal.

[13]  Fujie Xu,et al.  Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. , 2006, JAMA.

[14]  James B. Hill,et al.  Valacyclovir Prophylaxis to Prevent Recurrent Herpes at Delivery: A Randomized Clinical Trial , 2006, Obstetrics and gynecology.

[15]  L. Cormier,et al.  Neonatal Herpes Simplex Virus Infections in Canada: Results of a 3-Year National Prospective Study , 2006, Pediatrics.

[16]  T. Quinn,et al.  The Effects of Herpes Simplex Virus-2 on HIV-1 Acquisition and Transmission: A Review of Two Overlapping Epidemics , 2004, Journal of acquired immune deficiency syndromes.

[17]  James B. Hill,et al.  Acyclovir Prophylaxis to Prevent Herpes Simplex Virus Recurrence at Delivery: A Systematic Review , 2003, Obstetrics and gynecology.

[18]  Craig M. Roberts,et al.  Increasing Proportion of Herpes Simplex Virus Type 1 as a Cause of Genital Herpes Infection in College Students , 2003, Sexually transmitted diseases.

[19]  T. Kawana,et al.  Divergence of reiterated sequences in a series of genital isolates of herpes simplex virus type 1 from individual patients. , 2003, The Journal of general virology.

[20]  L. Corey,et al.  A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery. , 2003, American journal of obstetrics and gynecology.

[21]  J. Zeh,et al.  Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. , 2003, JAMA.

[22]  G. Löwhagen,et al.  Prevalence of Herpes Simplex Virus Antibodies in Childhood and Adolescence: A Cross-sectional Study , 2003, Scandinavian journal of infectious diseases.

[23]  Jennifer S. Smith,et al.  Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. , 2002, The Journal of infectious diseases.

[24]  Gynecologists.  ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 32, November 2001 (replaces Technical Bulletin Number 181, June 1993, and Committee Opinion Number 241, September 2000). Thyroid disease in pregnancy. , 2001, Obstetrics and gynecology.

[25]  S. Soong,et al.  Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. , 2001, Pediatrics.

[26]  S. Soong,et al.  Natural history of neonatal herpes simplex virus infections in the acyclovir era. , 2001, Pediatrics.

[27]  B. Roizman,et al.  Herpes simplex viruses: is a vaccine tenable? , 2002, The Journal of clinical investigation.

[28]  Robert E. Johnson,et al.  Herpes Simplex Virus Type 2 in the United States, 1976 to 1994 , 1997 .

[29]  R L Ashley,et al.  The acquisition of herpes simplex virus during pregnancy. , 1997, The New England journal of medicine.

[30]  C. Prober,et al.  Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy , 1992, The New England journal of medicine.

[31]  L. Corey,et al.  Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. , 1991, The New England journal of medicine.

[32]  D. Powell,et al.  A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group. , 1991, The New England journal of medicine.

[33]  A. Nahmias,et al.  Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. , 1990, Scandinavian journal of infectious diseases. Supplementum.

[34]  Steven T Baldwin,et al.  Intrauterine herpes simplex virus infection. , 1989, Teratology.

[35]  S. Soong,et al.  Changing presentation of herpes simplex virus infection in neonates. , 1988, The Journal of infectious diseases.

[36]  D. Powell,et al.  Intrauterine herpes simplex virus infections. , 1987, The Journal of pediatrics.

[37]  C. Prober,et al.  Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery. , 1986, The New England journal of medicine.

[38]  A. Arvin,et al.  Reasons for the absence of a history of recurrent genital infections in mothers of neonates infected with herpes simplex virus. , 1984, Pediatrics.

[39]  A. Nahmias,et al.  The natural history of herpes simplex virus infection of mother and newborn. , 1980, Pediatrics.

[40]  S. Soong,et al.  Vidarabine therapy of neonatal herpes simplex virus infection. , 1980, Pediatrics.

[41]  B. Roizman.  The structure and isomerization of herpes simplex virus genomes , 1979, Cell.

[42]  John E. Bennett,et al.  Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .

[43]  B. Roizman,et al.  Restriction endonuclease fingerprinting of herpes simplex virus DNA: a novel epidemiological tool applied to a nosocomial outbreak. , 1978, The Journal of infectious diseases.